Alveolar Macrophage Recruitment and Activation by Chronic Second Hand Smoke Exposure in Mice

REFERENCES

• Petty T L. Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest 2000; 117(5 Suppl 2)326S–31S
   PubMed Web of Science ®Google Scholar
• Ward M M, Javitz H S, Smith W M, Bakst A. Direct medical cost of chronic obstructive pulmonary disease in the U.S.A. Respir Med 2000; 94(11)1123–1129
   PubMed Web of Science ®Google Scholar
• Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Mondaldi Arch Chest Dis 2001; 56: 261–264
   PubMedGoogle Scholar
• Centers for Disase Control and Prevention. Chronic Obstructive Pulmonary Disease Surveillance-United States, 1971–2000. MMWR 2002; 51(SS-6)1–7
   Google Scholar
• Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5)1256–1276
   PubMedGoogle Scholar
• Thun M J, Myers D G, Day-Lally C, Namboodiri M M, Calle E E, Flanders W D, Adams S L, Heath C W. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control, D R Shopland, D M Burns, L Garfinkel, J M Samet. U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1997; 383–413, Smoking and Tobacco Control Monograph No. 8
   Google Scholar
• Robbins A S, Abbey D E, Lebowitz M D. Passive smoking and chronic respiratory disease symptoms in non-smoking adults. Int J Epidemiol 1993; 22(5)809–817
   PubMed Web of Science ®Google Scholar
• Dayal H H, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an industrialized urban population. Environ Res 1994; 65(2)161–171
   PubMed Web of Science ®Google Scholar
• Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard J P, Brandli O, Braun P, Bron C, Brutsche M, et al. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med 1994; 150: 1222–1228, (5 Pt 1)
   PubMed Web of Science ®Google Scholar
• Piitulainen E, Tornling G, Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax 1998; 53(11)939–943
   PubMed Web of Science ®Google Scholar
• Forastiere F, Mallone S, Lo Presti E, Baldacci S, Pistelli F, Simoni M, Scalera A, Pedreschi M, Pistelli R, Corbo G, Rapiti E, Agabiti N, Farchi S, Basso S, Chiaffi L, Matteelli G, Di Pede F, Carrozzi L, Viegi G. Characteristics of nonsmoking women exposed to spouses who smoke: epidemiologic study on environment and health in women from four Italian areas. Environ Health Perspect 2000; 108(12)1171–1177
   PubMed Web of Science ®Google Scholar
• Lee P N, Chamberlain J, Alderson M R. Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer 1986; 54(1)97–105
   PubMed Web of Science ®Google Scholar
• Kalandidi A, Trichopoulos D, Hatzakis A, Tzannes S, Saracci R. Passive smoking and chronic obstructive lung disease. Lancet 1987; 2(8571)1325–1326
   PubMed Web of Science ®Google Scholar
• Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J (Clin Res Ed) 1981; 282(6259)183–185
   PubMed Web of Science ®Google Scholar
• Sandler D P, Comstock G W, Helsing K J, Shore D L. Deaths from all causes in non-smokers who lived with smokers. Am J Public Health 1989; 79(2)163–167
   PubMed Web of Science ®Google Scholar
• Berglund D J, Abbey D E, Lebowitz M D, Knutsen S F, McDonnell W F. Respiratory symptoms and pulmonary function in an elderly nonsmoking population. Chest 1999; 115(1)49–59
   PubMed Web of Science ®Google Scholar
• U. S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA 2006
   Google Scholar
• Pirkle J L, Bernert J T, Caudill S P, Sosnoff C S, Pechacek T F. Trends in the exposure of nonsmokers in the U. S. population to secondhand smoke: 1988–2002. Environ Health Perspect 2006; 114(6)853–858
   PubMed Web of Science ®Google Scholar
• Traves S L, Culpitt S V, Russell R E, Barnes P J, Donnelly L E. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002; 57(7)590–595
   PubMed Web of Science ®Google Scholar
• Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD 2004; 1(2)155–164
   PubMedGoogle Scholar
• Aldonyte R, Jansson L, Piitulainen E, Janciauskiene S. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003; 4: 11
   PubMed Web of Science ®Google Scholar
• Di Francia M, Barbier D, Mege J L, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453–1455, (5 Pt 1)
   PubMed Web of Science ®Google Scholar
• Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 1998; 92(8)993–999
   PubMed Web of Science ®Google Scholar
• Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1215–1219, (4 Pt 1)
   PubMed Web of Science ®Google Scholar
• Eid A A, Ionescu A A, Nixon L S, Lewis-Jenkins V, Matthews S B, Griffiths T L, Shale D J. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414–1418, (8 Pt 1)
   PubMed Web of Science ®Google Scholar
• Keatings V M, Collins P D, Scott D M, Barnes P J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153(2)530–534
   PubMed Web of Science ®Google Scholar
• Woodruff P G, Koth L L, Yang Y H, Rodriguez M W, Favoreto S, Dolgano G M, Paquet A C, Erle D J. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005; 172(11)1383–1392
   PubMed Web of Science ®Google Scholar
• Hautamaki R D, Kobayashi D K, Senior R M, Shapiro S D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277(5334)2002–2004
   PubMed Web of Science ®Google Scholar
• Morris D G, Huang X, Kaminski N, Wang Y, Shapiro S D, Dolganov G, Glick A, Sheppard D. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003; 422(6928)169–173
   PubMed Web of Science ®Google Scholar
• Zheng T, Zhu Z, Wang Z, Homer R J, Ma B, Riese R J, Jr, Chapman H A, Jr, Shapiro S D, Elias J A. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106(9)1081–1093
   PubMed Web of Science ®Google Scholar
• Molet S, Belleguic C, Lena H, Germain N, Bertrand C P, Shapiro S D, Planquois J M, Delaval P, Lagente V. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005; 54(1)31–36
   PubMed Web of Science ®Google Scholar
• Demedts I K, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos G F, Pauwels R A, Brusselle G G. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006; 61(3)196–201
   PubMed Web of Science ®Google Scholar
• Grumelli S, Corry D B, Song L Z, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis D E, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1(1)e8
   PubMed Web of Science ®Google Scholar
• Teague S V, Pinkerton K E, Goldsmith M, Gebremichael A, Chang S, Jenkins R A, Moneyhun J H. Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol 1994; 6: 79–93
   Web of Science ®Google Scholar
• Koth L L, Alex B, Hawgood S, Nead M A, Sheppard D, Erle D J, Morris D G. Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1. Am J Respir Cell Mol Biol 2007; 37(6)651–659
   PubMed Web of Science ®Google Scholar
• Dolganov G M, Woodruff P G, Novikov A A, Zhang Y, Ferrando R E, Szubin R, Fahy J V. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+ -K+-Cl− cotransporter (NKCC1) in asthmatic subjects. Genome Res 2001; 11(9)1473–1483
   PubMed Web of Science ®Google Scholar
• Ochs M. A brief update on lung stereology. J Microsc 2006; 222: 188–200, (Pt 3)
   PubMed Web of Science ®Google Scholar
• Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, Nyengaard J R, Hawgood S. GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. Am J Physiol Lung Cell Mol Physiol 2004; 287(6)L1333–41
   PubMed Web of Science ®Google Scholar
• Barbers R G, Gong H, Jr, Tashkin D P, Oishi J, Wallace J M. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am Rev Respir Dis 1987; 135(6)1271–1275
   PubMed Web of Science ®Google Scholar
• Kuschner W G, D'Alessandro A, Wong H, Blanc P D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9(10)1989–1994
   PubMed Web of Science ®Google Scholar
• Wright J L, Churg A. Animal models of cigarette smoke-induced COPD. Chest 2002; 122(6 Suppl)301S–306S
   PubMed Web of Science ®Google Scholar
• Chung K F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34: 50s–59s
   PubMed Web of Science ®Google Scholar
• Finlay G A, Russell K J, McMahon K J, D'Arcy E M, Masterson J B, Fitz Gerald M X, O'Connor C M. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997; 52(6)502–506
   PubMed Web of Science ®Google Scholar
• Finlay G A, O'Driscoll L R, Russell K J, D'Arcy E M, Masterson J B, Fitz Gerald M X, O'Connor C M. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156(1)240–247
   PubMed Web of Science ®Google Scholar
• Segura-Valdez L, Pardo A, Gaxiola M, Uhal B D, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117(3)684–694
   PubMed Web of Science ®Google Scholar
• Takeyabu K, Betsuyaku T, Nishimura M, Yoshioka A, Tanino M, Miyamoto K, Kawakami Y. Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J 1998; 12(5)1033–1039
   PubMed Web of Science ®Google Scholar
• Takahashi H, Ishidoh K, Muno D, Ohwada A, Nukiwa T, Kominami E, Kira S. Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am Rev Respir Dis 1993; 147: 1562–1568, (6 Pt 1)
   PubMed Web of Science ®Google Scholar
• Reilly J J, Jr, Chen P, Sailor L Z, Wilcox D, Mason R W, Chapman H A, Jr. Cigarette smoking induces an elastolytic cysteine proteinase in macrophages distinct from cathepsin L. Am J Physiol 1991; 261: L41–48, (2 Pt 1)
   PubMed Web of Science ®Google Scholar
• Shapiro S D, Ingenito E P. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005; 32(5)367–372
   PubMed Web of Science ®Google Scholar
• Houghton A M, Quintero P A, Perkins D L, Kobayashi D K, Kelley D G, Marconcini L A, Mecham R P, Senior R M, Shapiro S D. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116(3)753–759
   PubMed Web of Science ®Google Scholar
• Capelli A, Di Stefano A, Gnemmi I, Balbo P, Cerutti C G, Balbi B, Lusuardi M, Donner C F. Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J 1999; 14(1)160–165
   PubMed Web of Science ®Google Scholar
• Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Activation of NK cells by CC chemokines. Chemotaxis, Ca2 + mobilization, and enzyme release. J Immunol 1996; 156(1)322–327
   PubMed Web of Science ®Google Scholar
• Bischoff S C, Krieger M, Brunner T, Dahinden C A. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 1992; 175(5)1271–1275
   PubMed Web of Science ®Google Scholar
• Karpus W J, Lukacs N W, Kennedy K J, Smith W S, Hurst S D, Barrett T A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997; 158(9)4129–4136
   PubMed Web of Science ®Google Scholar
• Ritter U, Moll H. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur J Immunol 2000; 30(11)3111–3120
   PubMed Web of Science ®Google Scholar
• Hakkinen T, Luoma J S, Hiltunen M O, Macphee C H, Milliner K J, Patel L, Rice S Q, Tew D G, Karkola K, Yla-Herttuala S. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999; 19(12)2909–2917
   PubMed Web of Science ®Google Scholar
• Tselepis A D, John Chapman M. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl 2002; 3(4)57–68
   PubMed Web of Science ®Google Scholar
• Macphee C H, Nelson J J, Zalewski A. Lipoprotein-associated phospholipase A2 as a target of therapy. Curr Opin Lipidol 2005; 16(4)442–446
   PubMed Web of Science ®Google Scholar
• Gelbman B D, Heguy A, O'Connor T P, Zabner J, Crystal R G. Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis. Respir Res 2007; 8: 10
   PubMed Web of Science ®Google Scholar
• Tuder R M, Petrache I, Elias J A, Voelkel N F, Henson P M. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003; 28(5)551–554
   PubMed Web of Science ®Google Scholar
• Hamerman J A, Jarjoura J R, Humphrey M B, Nakamura M C, Seaman W E, Lanier L L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006; 177(4)2051–2055
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu Y, Shi J, Larson D F, Watson R R. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med (Maywood) 2002; 227(9)823–829
   PubMed Web of Science ®Google Scholar
• Yuan H, Wong L S, Bhattacharya M, Ma C, Zafarani M, Yao M, Schneider M, Pitas R E, Martins-Green M. The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc Disord 2007; 7: 1
   PubMedGoogle Scholar
• Yu M, Pinkerton K E, Witschi H. Short-term exposure to aged and diluted sidestream cigarette smoke enhances ozone-induced lung injury in B6C3F1 mice. Toxicol Sci 2002; 65(1)99–106
   PubMed Web of Science ®Google Scholar
• Zhang Z, Araghiniknam M, Inserra P, Jiang S, Lee J, Chow S, Breceda V, Balagtas M, Witten M, Watson R R. Vitamin E supplementaion prevents lung dysfunction and lipid peroxidation in nude mice exposed to side-stream cigarette smoke. Nutr Res 1999; 19: 75–84
   Web of Science ®Google Scholar
• Zhang J, Jiang S, Watson R R. Antioxidant supplementation prevents oxidation and inflammatory responses induced by sidestream cigarette smoke in old mice. Environ Health Perspect 2001; 109(10)1007–1009
   PubMed Web of Science ®Google Scholar
• Mullick A E, McDonald J M, Melkonian G, Talbot P, Pinkerton K E, Rutledge J C. Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol Heart Circ Physiol 2002; 283(2)H591–597
   PubMed Web of Science ®Google Scholar
• Gairola C G, Drawdy M L, Block A E, Daugherty A. Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E-/- mice. Atherosclerosis 2001; 156(1)49–55
   PubMed Web of Science ®Google Scholar
• Torok J, Gvozdjakova A, Kucharska J, Balazovjech I, Kysela S, Simko F, Gvozdjak J. Passive smoking impairs endothelium-dependent relaxation of isolated rabbit arteries. Physiol Res 2000; 49(1)135–41
   PubMed Web of Science ®Google Scholar
• Witschi H, Espiritu I, Maronpot R R, Pinkerton K E, Jones A D. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 1997; 18(11)2035–2042
   PubMed Web of Science ®Google Scholar
• Witschi H, Espiritu I, Peake J L, Wu K, Maronpot R R, Pinkerton K E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997; 18(3)575–86
   PubMed Web of Science ®Google Scholar
• Witschi H, Espiritu I, Uyeminami D. Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis 1999; 20(7)1375–1378
   PubMed Web of Science ®Google Scholar
• Witschi H, Espiritu I, Yu M, Willits N H. The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice. Carcinogenesis 1998; 19(10)1789–1794
   PubMed Web of Science ®Google Scholar
• Witschi H, Uyeminami D, Moran D, Espiritu I. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure. Carcinogenesis 2000; 21(5)977–982
   PubMed Web of Science ®Google Scholar
• Bogen K T, Witschi H. Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk. Carcinogenesis 2002; 23(3)511–519
   PubMed Web of Science ®Google Scholar
• Hahn F F, Gigliotti A P, Hutt J A, March T H, Mauderly J L. A review of the histopathology of cigarette smoke-induced lung cancer in rats and mice. Int J Toxicol 2007; 26(4)307–13
   PubMed Web of Science ®Google Scholar